Skip to main content

Exploring the diet-microbiota axis for immunomodulation and organ protection in hypertension

Project description

Your gastrointestinal inhabitants may indirectly modulate hypertension

According to the World Health Organization, more than 1 billion people globally have hypertension (high blood pressure) and fewer than 20 % of them have it under control. Hypertension can cause damage to numerous organs, including the heart, kidneys, brain and eyes, and it is a major cause of premature death. Scientists have recently shown a link between dietary salt intake and hypertension that is mediated by an immune response regulated by gut microbiota. The EU-funded HyperBiota project is untangling the complicated pathway from diet to immunity to hypertension with the goal of enabling personalised hypertension therapy based on microbiome-related immunonutrition. Aside from treating hypertension, it could significantly decrease hypertension-associated organ damage.

Host institution

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Net EU contribution
€ 1 497 250,00
Address
Chariteplatz 1
10117 Berlin
Germany

See on map

Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Other funding
€ 1 497 250,00

Beneficiaries (1)

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Germany
Net EU contribution
€ 1 497 250,00
Address
Chariteplatz 1
10117 Berlin

See on map

Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Other funding
€ 1 497 250,00